SCHEMBL10576401

SCHEMBL10576401

CCCS(=O)(=O)NCC(C)(C)c1ccc2nc(-c3ccncc3)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 1/20 0.48
▸ CYP2C9 P11712 5/20 0.47
▸ CYP2C19 P33261 5/20 0.47
▸ CYP1A2 P05177 4/20 0.47
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PKN1 Q16512 4/20 0.45
▸ PKN2 Q16513 4/20 0.45
▸ CYP3A4 P08684 4/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ATM Q13315 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CHEK2 O96017 1/20 0.41
▸ NPBWR1 P48145 2/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10576389 0.92 SCD (0.41) SCDCYP2C9CYP2C19CYP1A2NPC1
SCHEMBL10578129 0.87 SCD (0.55) SCDNPC1RAB9APKN1PKN2
SCHEMBL10576976 0.87 SLC2A1 (0.50) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL10572234 0.84 SCD (0.49) SCDCYP2C9CYP2C19CYP1A2NPC1
SCHEMBL10579006 0.84 SCD (0.48) SCDCYP2C9CYP2C19CYP1A2NPC1
SCHEMBL10578953 0.83 SCD (0.50) SCDCYP2C9CYP2C19CYP1A2NPC1
SCHEMBL10574710 0.80 NPC1 (0.51) SCDCYP2C9CYP2C19CYP1A2NPC1
SCHEMBL10576972 0.79 SMN1; SMN2 (0.44) CYP2C9CYP2C19CYP1A2NPC1RAB9A
SCHEMBL10578768 0.79 ALDH1A1 (0.60) SCDNPC1RAB9APKN1PKN2
SCHEMBL10578118 0.79 SCD (0.46) SCDCYP2C9CYP2C19CYP1A2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback